Compile Data Set for Download or QSAR
Report error Found 122 Enz. Inhib. hit(s) with all data for entry = 3182
TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393520BDBM393520(US9969687, Compound 183)
Affinity DataKi:  3nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393561BDBM393561(US9969687, Compound 232)
Affinity DataKi:  3nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393572BDBM393572(US9969687, Compound 244)
Affinity DataKi:  3nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393600BDBM393600(US9969687, Compound 281)
Affinity DataKi:  4nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393553BDBM393553(US9969687, Compound 224)
Affinity DataKi:  6nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393530BDBM393530(US9969687, Compound 194)
Affinity DataKi:  6nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393557BDBM393557(US9969687, Compound 228)
Affinity DataKi:  6nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393559BDBM393559(US9969687, Compound 230)
Affinity DataKi:  6nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393569BDBM393569(US9969687, Compound 241)
Affinity DataKi:  7nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393566BDBM393566(US9969687, Compound 237)
Affinity DataKi:  9nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393534BDBM393534(US9969687, Compound 199)
Affinity DataKi:  10nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393606BDBM393606(US9969687, Compound 287)
Affinity DataKi:  10nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393585BDBM393585(US9969687, Compound 261)
Affinity DataKi:  11nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393552BDBM393552(US9969687, Compound 222)
Affinity DataKi:  12nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393603BDBM393603(US9969687, Compound 284)
Affinity DataKi:  12nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393516BDBM393516(US9969687, Compound 175)
Affinity DataKi:  12nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393528BDBM393528(US9969687, Compound 192)
Affinity DataKi:  12nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393517BDBM393517(US9969687, Compound 176)
Affinity DataKi:  13nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393567BDBM393567(US9969687, Compound 238)
Affinity DataKi:  13nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393609BDBM393609(US9969687, Compound 290)
Affinity DataKi:  14nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393605BDBM393605(US9969687, Compound 286)
Affinity DataKi:  14nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393610BDBM393610(US9969687, Compound 291)
Affinity DataKi:  15nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393611BDBM393611(US9969687, Compound 292)
Affinity DataKi:  16nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393541BDBM393541(US9969687, Compound 208)
Affinity DataKi:  16nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393536BDBM393536(US9969687, Compound 201)
Affinity DataKi:  17nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393597BDBM393597(US9969687, Compound 278)
Affinity DataKi:  17nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393598BDBM393598(US9969687, Compound 279)
Affinity DataKi:  17nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393580BDBM393580(US9969687, Compound 256)
Affinity DataKi:  18nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393588BDBM393588(US9969687, Compound 264)
Affinity DataKi:  18nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393602BDBM393602(US9969687, Compound 283)
Affinity DataKi:  20nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393581BDBM393581(US9969687, Compound 257)
Affinity DataKi:  21nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393529BDBM393529(US9969687, Compound 193)
Affinity DataKi:  21nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393562BDBM393562(US9969687, Compound 233)
Affinity DataKi:  21nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393584BDBM393584(US9969687, Compound 260)
Affinity DataKi:  22nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393568BDBM393568(US9969687, Compound 239)
Affinity DataKi:  23nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393601BDBM393601(US9969687, Compound 282)
Affinity DataKi:  23nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393522BDBM393522(US9969687, Compound 185)
Affinity DataKi:  23nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393555BDBM393555(US9969687, Compound 226)
Affinity DataKi:  23nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393545BDBM393545(US9969687, Compound 213)
Affinity DataKi:  23nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393509BDBM393509(US9969687, Compound 144)
Affinity DataKi:  23nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393607BDBM393607(US9969687, Compound 288)
Affinity DataKi:  23nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393521BDBM393521(US9969687, Compound 184)
Affinity DataKi:  24nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393587BDBM393587(US9969687, Compound 263)
Affinity DataKi:  25nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393589BDBM393589(US9969687, Compound 266)
Affinity DataKi:  25nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393549BDBM393549(US9969687, Compound 218)
Affinity DataKi:  26nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393494BDBM393494(US9969687, Compound 64)
Affinity DataKi:  27nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393593BDBM393593(US9969687, Compound 272)
Affinity DataKi:  29nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393539BDBM393539(US9969687, Compound 204)
Affinity DataKi:  30nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393550BDBM393550(US9969687, Compound 219)
Affinity DataKi:  30nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

TargetC-C chemokine receptor type 9(Human)
Norgine

US Patent
LigandChemical structure of BindingDB Monomer ID 393565BDBM393565(US9969687, Compound 236)
Affinity DataKi:  32nMAssay Description:A calcium flux assay was used to determine the ability of the compounds to interfere with the binding between CCR9 and its chemokine ligand (TECK) in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/6/2020
Entry Details
US Patent

Displayed 1 to 50 (of 122 total ) | Next | Last >>
Jump to: